AC
TWST icon

Armistice Capital’s Twist Bioscience TWST Stock Holding History

Armistice Capital’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.6M Buy
+142,000
New +$9.24M 0.18% 82

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Armistice Capital's TWST Position: Q2 2026 in Review

Armistice Capital opened a new position in Twist Bioscience (TWST) in Q2 2026: 142,000 shares worth $14.6M. The stake represents 0.18% of the portfolio and ranks #82 among its holdings.

335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Armistice Capital held 142,000 shares of Twist Bioscience worth $14.6M as of Q2 2026.
  • Twist Bioscience was a new Armistice Capital position in Q2 2026.
  • Twist Bioscience made up 0.18% of Armistice Capital's portfolio in Q2 2026, its #82 holding.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.